Early detection is key to achieving an optimal prognosis. Are you willing to dispute that? They aren't going to throw away this test, because it is TOO GOOD.
"I do agree though (thanks to Goldseeker's repeated pounding) that any Recaf will need to be backed up by other cancer specific tests to make it plausible. Hence, it will have to go to trials with another specific marker to get approval."
So a doctor recommending a PSA test would also run a Recaf test. The Recaf test would just help confirm the results of the PSA test. I thought this was the plan ever since Abbott joined us. Once this got FDA approval, other joint tests like CA-125 could be applied for as similar tests.....
News 
Market Data 
Discover 
AI
